Anti-Mullerian hormone and AMH gene (rs3741664) polymorphism analysis in Iraqi women with polycystic ovary syndrome

Ammar Mohammad Mustafa; Maan Hasan Salih; Adnan Fahdel Al-Azzawie

doi:10.51248/.v43i5.3497

Authors

Ammar Mohammad Mustafa
Maan Hasan Salih
Adnan Fahdel Al-Azzawie

DOI:

https://doi.org/10.51248/.v43i5.3497

Keywords:

Polycystic ovary syndrome, PCOS, AMH hormone, rs3741664, polymorphism

Abstract

Introduction and Aim: Polycystic ovarian syndrome (PCOS) is a complex and heterogeneous endocrine disorder, with the underlying pathogenic mechanisms yet unknown. The purpose of this study was to evaluate the hormonal profile of women with PCOS, as well as their Anti-Mullerian hormonal (AMH) levels and the associated AMH gene (rs3741664) polymorphism.

Materials and Methods: The current study included 60 polycystic ovary syndrome (PCOs) patients and 30 healthy women. Serum levels of LH, FSH, TSH, Estrogen and AMH were measured. Polymerase chain reaction (PCR) method was used to genotype the AMH gene (rs3741664). The statistical analysis was performed using GrapPad Prism 9. The rs3741664 genotypes and allele frequencies were calculated and the Hardy-Weinberg equilibrium was utilized to examine the outcomes.

Results: There was a substantial rise in LH, TSH, Estrogen, and AMH blood levels in PCOS females as compared to the control female group (P value = 0.05). In contrast, the serum level of FSH was not significantly increased at p value = 0.05. Polymorphism rs3741664 was not significantly associated with serum AMH levels in the population study.

Conclusion: LH, TSH, Estrogen, and AMH levels are elevated in PCOS women. As a result, these hormones are regarded as indicators for identifying PCOS in Iraqi females. Polymorphism rs3741664 was not significantly associated with serum AMH levels in the population study. AMH level not significantly associated with genotypes of AMH rs3741664 gene.

Author Biographies

Ammar Mohammad Mustafa

Ministry of Health, Kirkuk Health Department, Kirkuk, Iraq

Maan Hasan Salih

Department of Biology, College of Science, Tikrit University, Tikrit, Iraq

Adnan Fahdel Al-Azzawie

Department of Biology, College of Science, Tikrit University, Tikrit, Iraq

References

Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., Yildiz, B.O. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction. 2016; 31(12):2841-2855.

Naz, M.S.G., Tehrani, F.R., Majd, H.A., Ahmadi, F., Ozgoli, G., Fakari, F.R, et al., The prevalence of polycystic ovary syndrome in adolescents: A systematic review and meta-analysis. International Journal of Reproductive Biomedicine. 2019; 17(8):533- 542.

Hegde, P., Shetty, P.K., Shetty, S.S., Manjeera, L., Shetty, D.P. A study on changes in hormonal disruption in polycystic ovary syndrome with advancing age and body mass index. Biomedicine. 2022 Jul 3;42(3):461-468.

Narayanaswamy, N.L., Ramanathan, F., Manjuladevi, M.T. Diagnostic utility of serum anti-Mullerian hormone levels in south Indian women with polycystic ovarian syndrome. Biomedicine. 2023 Sep 18;43(4):1215-1219.

Dev, D., Dutta, P. A novel approach to treat polycystic ovarian syndrome (PCOS) patients. Biomedicine. 2022 Sep 12;42(4):841-843.

Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction. 2004 ;19(1):41-47.

Kakoly, N.S., Earnest, A., Teede, H.J., Moran, L.J., Joham, A.E. The impact of obesity on the incidence of type 2 diabetes among women with polycystic ovary syndrome. Diabetes Care. 2019;42(4):560-567.

Joham, A.E., Teede, H.J., Ranasinha, S., Zoungas, S., Boyle, J. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study. Journal of Women's Health. 2015;24(4):299-307.

Cooney, L.G., Lee, I., Sammel, M.D., Dokras, A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction. 2017;32(5):1075-1091.

Tay, C.T., Teede, H.J., Hill, B., Loxton, D., Joham, A.E. Increased prevalence of eating disorders, low self-esteem, and psychological distress in women with polycystic ovary syndrome: a community-based cohort study. Fertility and Sterility. 2019 1;112(2):353-361.

Auda, S.A., Gatea, E.A., Radhi, Z.A. Evaluation of thyroid autoimmunity markers in polycystic ovarian syndrome in women. Biomedicine. 2023 Jul 1;43(3):893-896.

International evidence based guideline for the assessment and management of polycystic ovary syndrome. Monash University, Melbourne, Australia. 2018.

Teede, H.J., Misso, M.L., Costello, M.F., Dokras, A., Laven, J., Moran, L, et al., Recommendations from the international evidence based guideline for the assessment and management of polycystic ovary syndrome. Human reproduction. 2018 ;33(9):1602-1618.

Weenen, C., Laven, J.S., Von Bergh, A.R., Cranfield, M., Groome, N.P., Visser, J.A, et al., Anti Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Molecular Human Reproduction. 2004;10(2):77-83.

Cohen Haguenauer, O., Picard, J.Y., Mattei, M.G., Serero, S., Van Cong, N., De T, et al., Mapping of the gene for anti-Mullerian hormone to the short arm of human chromosome 19. Cytogenetic and Genome Research. 1987 May 9;44(1):2-6.

Depmann, M., Van Disseldorp, J., Broer, S.L., Eijkemans, M.J., Laven, J.S., Visser, J.A, et al., Fluctuations in antiMullerian hormone levels throughout the menstrual cycle parallel fluctuations in the antral follicle count: a cohort study. Acta obstetricia et gynecologica Scandinavica. 2016 Jul;95(7):820-828.

Srijyothi, L., Ponne, S., Prathama, T., Ashok, C., Baluchamy, S. Roles of non-coding RNAs in transcriptional regulation. Transcriptional and Post-transcriptional Regulation. 2018; 55-61.

Abbara, A., Eng, P.C., Phylactou, M., Clarke, S.A., Hunjan, T., Roberts, R, et al, Anti-müllerian hormone (AMH) in the diagnosis of menstrual disturbance due to polycystic ovarian syndrome. Frontiers in Endocrinology. 2019; 10:656.

Bremer, A.A. Polycystic ovary syndrome in the pediatric population. Metabolic Syndrome and Related Disorders. 2010;8(5):375-394.

Kahsar-Miller, M., Azziz R. The development of the polycystic ovary syndrome: family history as a risk factor. Trends in Endocrinology & Metabolism. 1998; 9(2):55-58.

Choudhary, A., Jain, S., Chaudhari, P. Prevalence and symptomatology of polycystic ovarian syndrome in Indian women: is there a rising incidence. Int J Reprod Contracept Obstet Gynecol. 2017; 6(11):4971-4975.

Meczekalski, B., Niwczyk, O., Kostrzak, A., Maciejewska-Jeske, M., Bala, G., Szeliga, A. PCOS in Adolescents—Ongoing riddles in diagnosis and treatment. Journal of Clinical Medicine. 2023; 12(3):1221.

Khashchenko, E., Uvarova, E., Vysokikh, M., Ivanets, T., Krechetova, L., Tarasova, N. et al., The relevant hormonal levels and diagnostic features of polycystic ovary syndrome in adolescents. Journal of Clinical Medicine. 2020;9(6):1831.

Bhattacharya K, Saha I, Sen D, Bose C, Chaudhuri GR, Dutta S, et al., Role of anti-Mullerian hormone in polycystic ovary syndrome. Middle East Fertility Society Journal. 2022; 27(1):1-10.

Rojhani, E., Rahmati, M., Firouzi, F., Saei Ghare Naz, M., Azizi, F. Ramezani Tehrani F. Polycystic Ovary Syndrome, Subclinical Hypothyroidism, the Cut-Off Value of Thyroid Stimulating Hormone; Is There a Link? Findings of a Population-Based Study. Diagnostics. 2023; 13(2):316- 320.

Mohammad, M.B., Seghinsara, A.M. Polycystic ovary syndrome (PCOS), diagnostic criteria, and AMH. Asian Pacific Journal of Cancer Prevention: APJCP. 2017; 18(1):17 -21.

Cimino, I., Casoni, F., Liu, X., Messina, A., Parkash, J., Jamin, S.P, et al., Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nature Communications. 2016; 7(1):10055.

Taylor, A.E., McCourt, B., Martin, K.A., Anderson, E.J., Adams, J.M., Schoenfeld, D, et al., Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism. 1997; 82(7):2248-2256.

Wang, F., Niu, W.B., Kong, H.J., Guo, Y.H.,Sun, Y.P. The role of AMH and its receptor SNP in the pathogenesis of PCOS. Molecular and Cellular Endocrinology. 2017; 439:363-368.

Rafaa, T.A., Suleiman, A.A., Dawood, M.F., Al-Rawi, A.M. Association of two single nucleotide polymorphisms rs10407022 and rs3741664 with the risk of primary ovarian insufficiency in a sample of Iraqi women. Molecular Biology Research Communications. 2020; 9(4):141-144.

Vallero, D.A. Waste management accountability: risk, reliability, and resilience. In Waste 2019 Jan 1 (pp. 693-740). Academic Press.

Moolhuijsen, L.M., Louwers, Y.V., McLuskey, A., Broer, L., Uitterlinden, A.G., Verdiesen, R.M, et al., Association between an AMH promoter polymorphism and serum AMH levels in PCOS patients. Human Reproduction. 2022; 37(7):1544-1556.